Skip to main content
. 2018 May 22;9:1115. doi: 10.3389/fimmu.2018.01115

Figure 7.

Figure 7

Effect of nanoparticles (NPs) on expression of surface activation markers in the presence of endocytosis and phagocytosis inhibitors. MHC class I (A), MHC class II (B), CD40 (C), CD86 (D), and CD80 (E) expression on the JAWS II cells after 6 h exposure to 2.5 µg/ml 10 nm (S), 37 nm (M), 59 nm (L) TA-AgNPs and 10 nm (S), 34 nm (M), 62 nm (L) TA-AuNPs with or without pretreatment with 10 µg/ml monodansyl cadeverine (MDC), and 5 µg/ml cytochalasin D (CChD). Each bar represents the mean from three experiments (N = 3) ± S.E.M. *Significant differences with p ≤ 0.05, **p ≤ 0.01 in comparison to untreated control, ‡Significant differences with p ≤ 0.05 in comparison to inhibitor treatment.